knowledge -WSS

knowledge

author：leisure time 2025-10-01 04:13:49 - browse：871

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： A daunting task: navigating dual Medicare, Medicaid eligibility

WSS

Study: AI not yet building 'n

Researchers on aging grapple with how to calculate biological age

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Astellas still sees hope in its gene therapy after four deaths

Weight loss drug costs may need more research, senator suggests

hotspot

knowledge

explore

At least 13 dead in Texas as scorching temps continue

Weight loss drug costs may need more research, senator suggests

Activists slam private health insurers over coverage restrictions

Poor hospice wound care hurts patients and families

State Dept. review finds Biden bears some blame for Afghanistan failures

Researchers on aging grapple with how to calculate biological age

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A daunting task: navigating dual Medicare, Medicaid eligibility

Heart attack and stroke risk calculators need revising

Readout LOUD podcast: brain research, obesity drug sales, Novartis

knowledge

Anthos stroke drug appears safer than common blood thinner

World's first CRISPR

Study: AI not yet building 'n

Readout LOUD podcast: What to know about H5N1 bird flu

Does good food count as health care? Study aims to find out

A daunting task: navigating dual Medicare, Medicaid eligibility

explore

focus

entertainment

hotspot